Resistance patterns to anti-PD-1 therapy in metastatic melanoma

被引：3
|
作者：
Ozgun, Alpaslan
Sondak, Vernon K.
Markowitz, Joseph
机构：
[1] Univ S Florida, Morsani Coll Med, Moffitt Canc Ctr, Dept Cutaneous Oncol, Tampa, FL USA
[2] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Dept Cutaneous Oncol, Tampa, FL USA
来源：
CHINESE CLINICAL ONCOLOGY | 2016年 / 5卷 / 06期
关键词：
D O I：
10.21037/cco.2016.08.01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Outcomes of adjuvant therapy with anti-PD-1 antibody for mucosal melanoma
    Okumura, M.
    Ogata, D.
    Namikawa, K.
    Nakano, E.
    Omura, G.
    Honma, Y.
    Ishiyama, K.
    Tsukamoto, S.
    Matsui, Y.
    Ishikawa, M.
    Suzuki, S.
    Kanemitsu, Y.
    Daiko, H.
    Yoshimoto, S.
    Kato, K.
    Yamazaki, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S1339 - S1339
  • [42] Safety, activity, and biomarkers for neoadjuvant anti-PD-1 therapy in melanoma
    Huang, Alexander C.
    Xu, Xiowei
    Orlowski, Robert J.
    George, Sangeeth M.
    Chilukuri, Lakshmi
    Kozlov, Andrew
    Carberry, Mary
    Giles, Lydia
    McGettigan, Suzanne
    Kreider, Kristin
    Yearley, Jennifer H.
    Annamalai, Lakshmanan
    Linette, Gerald
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Farwell, Michael
    Wherry, John
    Karakousis, Giorgos
    Gangadhar, Tara
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
    Babacan, Nalan Akgul
    Eroglu, Zeynep
    CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
  • [44] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Parakh, Sagun
    Park, John J.
    Mendis, Shehara
    Rai, Rajat
    Xu, Wen
    Lo, Serigne
    Drummond, Martin
    Rowe, Catherine
    Wong, Annie
    McArthur, Grant
    Haydon, Andrew
    Andrews, Miles C.
    Cebon, Jonathan
    Guminski, Alex
    Kefford, Richard F.
    Long, Georgina V.
    Menzies, Alexander M.
    Klein, Oliver
    Carlino, Matteo S.
    BRITISH JOURNAL OF CANCER, 2017, 116 (12) : 1558 - 1563
  • [45] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Park, J. J.
    Parakh, S.
    Mendis, S.
    Rai, R.
    Lo, S.
    Haydon, A.
    Andrews, M. C.
    Cebon, J.
    Guminski, A.
    Kefford, R.
    Long, G. V.
    Menzies, A. M.
    Klein, O.
    Carlino, M. S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
    Nalan Akgul Babacan
    Zeynep Eroglu
    Current Oncology Reports, 2020, 22
  • [47] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Sagun Parakh
    John J Park
    Shehara Mendis
    Rajat Rai
    Wen Xu
    Serigne Lo
    Martin Drummond
    Catherine Rowe
    Annie Wong
    Grant McArthur
    Andrew Haydon
    Miles C Andrews
    Jonathan Cebon
    Alex Guminski
    Richard F Kefford
    Georgina V Long
    Alexander M Menzies
    Oliver Klein
    Matteo S Carlino
    British Journal of Cancer, 2017, 116 : 1558 - 1563
  • [48] Low-dose ipilimumab combined with anti-PD-1 immunotherapy in patients with metastatic melanoma following anti-PD-1 treatment failure
    Klee, Gina
    Kurzhals, Jonas
    Hagelstein, Victoria
    Zillikens, Detlef
    Recke, Andreas
    Langan, Ewan A.
    Terheyden, Patrick
    MELANOMA RESEARCH, 2021, 31 (05) : 464 - 471
  • [49] Safety and Activity of Combined Radiation Therapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) With Metastatic Melanoma
    Liniker, E.
    Kong, B.
    Menzies, A. M.
    Cooper, A. J.
    Kefford, R. F.
    Fogarty, G. B.
    Guminski, A.
    Carlino, M. S.
    Wang, T. W.
    Long, G. V.
    Hong, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E635 - E635
  • [50] Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy
    da Silva, Ines Pires
    Lo, Serigne
    Quek, Camelia
    Gonzalez, Maria
    Carlino, Matteo S.
    Long, Georgina, V
    Menzies, Alexander M.
    CANCER, 2020, 126 (01) : 86 - 97
12345